Clarify Pharma in line for Aquis quotation

Clarify Pharma is likely to be one of the next in line to float on the Access segment of the Aquis Stock Exchange. It has directors and investors in common with NFT Investments (LON: NFT) and Dispersion Holdings.

The stated strategy of Clarify Pharma is investing in alternative therapies and sciences. The focus is psychedelic medicine companies with clear paths to revenues. This could include clinics, biopharma companies and medical technology businesses.

There is already a website up and running (www.clarifypharma.com) and it has details of advisers and share capital ready for the Aqui...

Previous articleikigai launches first fintech in the UK to combine everyday banking and wealth management in one app
Next articleRevolting shareholders: Foxtons bonus upset
Avatar photo
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.